Doctor Uugantsetseg Munkhjargal

University of Tokushima, Tokushima (Japan)

Follow

Contributor content

A selective mineralocorticoid receptor blocker, esaxerenone, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein e-deficient mice

Presentation

A selective mineralocorticoid receptor blocker, esaxerenone, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein e-deficient mice

ESC 365 is supported by

novartis

Explore sponsored resources